- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
- Report
- July 2024
- 288 Pages
Global
From €5388EUR$5,817USD£4,350GBP
- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
Indinavir is a type of immune disorder drug used to treat HIV/AIDS. It is a protease inhibitor, meaning it blocks the action of protease enzymes, which are necessary for the virus to replicate. It is usually used in combination with other antiretroviral drugs to reduce the amount of HIV in the body. Indinavir is also used to prevent HIV infection in people who are at high risk of contracting the virus.
Indinavir is generally well-tolerated, but can cause side effects such as nausea, vomiting, and diarrhea. It can also interact with other medications, so it is important to discuss all medications with a doctor before taking Indinavir.
The Indinavir market is a competitive one, with many companies offering their own versions of the drug. Some of the companies in the market include Merck, Bristol-Myers Squibb, GlaxoSmithKline, and Pfizer. Show Less Read more